News

Deal Announcements

Ablative Solutions Adds Venture Capital Debt

Friday, August 16, 2013 5:35:00 AM PDT | VentureDeal
   Kalamazoo, Michigan  --  Medical device company Ablative Solutions has landed $705,000 in additional venture capital debt investment, according to an SEC regulatory filing.

Ablative is developing endovascular catheter technology for the treatment of hypertension and related diseases.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Ablative is still seeking $2.295 million in additional debt financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1